Stack M - Search Results

1

Utility of paraneoplastic antigens as biomarkers for surveillance and prediction of recurrence in ovarian cancer.

Chatterjee M, Hurley LC, Levin NK, Stack M, Tainsky MA. Chatterjee M, et al. Among authors: stack m. Cancer Biomark. 2017 Dec 6;20(4):369-387. doi: 10.3233/CBM-170652. Cancer Biomark. 2017. PMID: 29125478 Free PMC article.

2

Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.

Mills GB, Eder A, Fang X, Hasegawa Y, Mao M, Lu Y, Tanyi J, Tabassam FH, Wiener J, Lapushin R, Yu S, Parrott JA, Compton T, Tribley W, Fishman D, Stack MS, Gaudette D, Jaffe R, Furui T, Aoki J, Erickson JR. Mills GB, et al. Among authors: stack ms. Cancer Treat Res. 2002;107:259-83. doi: 10.1007/978-1-4757-3587-1_12. Cancer Treat Res. 2002. PMID: 11775454 Review.

3

Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.

Moss NM, Barbolina MV, Liu Y, Sun L, Munshi HG, Stack MS. Moss NM, et al. Among authors: stack ms. Cancer Res. 2009 Sep 1;69(17):7121-9. doi: 10.1158/0008-5472.CAN-08-4151. Epub 2009 Aug 25. Cancer Res. 2009. PMID: 19706774 Free PMC article.

4

Metalloproteinases in Ovarian Cancer.

Carey P, Low E, Harper E, Stack MS. Carey P, et al. Among authors: stack ms. Int J Mol Sci. 2021 Mar 26;22(7):3403. doi: 10.3390/ijms22073403. Int J Mol Sci. 2021. PMID: 33810259 Free PMC article. Review.

5

Ovarian cancer-associated proteinases.

Ghosh S, Wu Y, Stack MS. Ghosh S, et al. Among authors: stack ms. Cancer Treat Res. 2002;107:331-51. doi: 10.1007/978-1-4757-3587-1_16. Cancer Treat Res. 2002. PMID: 11775460 Review. No abstract available.

6

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.

Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Graves LE, et al. Among authors: stack ms. Cancer Res. 2004 Oct 1;64(19):7045-9. doi: 10.1158/0008-5472.CAN-04-1800. Cancer Res. 2004. PMID: 15466198

7

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer.

Drakes ML, Mehrotra S, Aldulescu M, Potkul RK, Liu Y, Grisoli A, Joyce C, O'Brien TE, Stack MS, Stiff PJ. Drakes ML, et al. Among authors: stack ms. J Ovarian Res. 2018 May 30;11(1):43. doi: 10.1186/s13048-018-0414-z. J Ovarian Res. 2018. PMID: 29843813 Free PMC article.

8

Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.

Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Symowicz J, et al. Among authors: stack ms. Cancer Res. 2005 Mar 15;65(6):2234-42. doi: 10.1158/0008.5472.CAN-04-2781. Cancer Res. 2005. PMID: 15781636

9

Multiparity activates interferon pathways in peritoneal adipose tissue and decreases susceptibility to ovarian cancer metastasis in a murine allograft model.

Loughran EA, Phan RC, Leonard AK, Tarwater L, Asem M, Liu Y, Yang J, Klymenko Y, Johnson J, Shi Z, Hilliard TS, Blumenthaler M, Leevy M, Ravosa MJ, Stack MS. Loughran EA, et al. Among authors: stack ms. Cancer Lett. 2017 Dec 28;411:74-81. doi: 10.1016/j.canlet.2017.09.028. Epub 2017 Sep 28. Cancer Lett. 2017. PMID: 28964786 Free PMC article.

10

Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.

Asem M, Young AM, Oyama C, Claure De La Zerda A, Liu Y, Yang J, Hilliard TS, Johnson J, Harper EI, Guldner I, Zhang S, Page-Mayberry T, Kaliney WJ, Stack MS. Asem M, et al. Among authors: stack ms. Cancer Res. 2020 Mar 1;80(5):1156-1170. doi: 10.1158/0008-5472.CAN-19-1601. Epub 2020 Jan 13. Cancer Res. 2020. PMID: 31932454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

453 results

Search Page